CME: Improving the Management of Severe Asthma in Patients with Type 2 Inflammation

CME: Improving the Management of Severe Asthma in Patients with Type 2 Inflammation

Credits:
0.50 AMA PRA Category 1 Credit(s)™ 0.50 AANP Contact Hours 0.50 AAPA Category 1 Credit(s)

Launch Date:
28-Feb-19
Expiration Date:
28-Feb-20

PRIMARY AUDIENCE:

Primary care physicians, NPs, PAs, and other clinicians who care for patients with asthma.

Nicola A. Hanania, MD, MS
Associate Professor of Medicine
Pulmonary and Critical Care Medicine
Director, Airways Clinical Research Center
Baylor College of Medicine
Houston, TX

Reynold A. Panettieri, Jr., MD
Vice Chancellor, Translational Medicine and Science
Director, Rutgers Institute for Translational Medicine and Science
Professor of Medicine, Robert Wood Johnson Medical School
Emeritus Professor of Medicine, University of Pennsylvania
Rutgers Institute for Translational Medicine and Science
New Brunswick, NJ 

CONTINUING EDUCATION CREDIT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy and MCM Education. Purdue University is accredited by the ACCME to provide continuing medical education for physicians. 

Purdue University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This activity is approved for 0.5 contact hour(s) of continuing education (which includes 0.25 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19023554. This activity was planned in accordance with AANP Accreditation Standards and Policies. 

 

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid for one year from 02/28/2019. PAs should only claim credit commensurate with the extent of their participation.

 

 

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Which factors should be considered before escalating treatments in children with severe therapy-resistant #asthma? https://t.…
9hreplyretweetfavorite
Interasma RT @Aller_MD: Analgesics in pregnancy do not seem to cause offspring #asthma https://t.co/pcwbWUNheb
9hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergists on Social Media! https://t.co/G1CYpYKwAy
9hreplyretweetfavorite
Interasma RT @Aller_MD: Mother's diet during pregnancy can impact lung-specific genes of her offspring https://t.co/cOD1iWDLx5
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma